| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Ann Thorac Surg 1998;65:1415-1419
© 1998 The Society of Thoracic Surgeons
a Section of Thoracic Surgery, Department of Surgery, University of Minnesota, Minneapolis, Minnesota, USA
Accepted for publication November 13, 1997.
Address reprint requests to Dr Salerno, Section of Thoracic Surgery, Department of Surgery, Box 207 UMHC, 420 Delaware St. SE, Minneapolis, MN 55455
e-mail: (saler002{at}maroon.tc.umn.edu)
Background. Medical management for invasive pulmonary aspergillosis (IPA) is often unsatisfactory. Antifungal therapy may be unable to eradicate IPA in the immunocompromised or neutropenic patient.
Methods. We retrospectively reviewed the surgical management of IPA in 13 immunocompromised patients at our institution. Twelve patients underwent perioperative bone marrow transplantation (4 autologous, 8 allogenic). All 13 patients received antifungal therapy. Eleven patients were neutropenic at the time of operation.
Results. The mean interval from diagnosis of aspergillosis to operation was 42 days (range, 3 to 135 days). Eighteen operations were performed on the 13 patients. Seven patients had resections from multiple pulmonary sites, whereas 6 had a single lesion resected. The average lesion resected was 3.7 cm in greatest diameter (range, 1 to 9 cm). After a mean follow-up of 21 months (range, 0 to 9 years), 3 patients (23%) are alive with no evidence of aspergillosis, 6 patients (46%) died without evidence of aspergillosis, and 4 patients (31%) died secondary to aspergillus infection. All 4 patients who died of aspergillus infection received an allogenic bone marrow transplantation. Two patients with direct extrapulmonic extension of IPA at time of operation died of recurrent aspergillus infections. Three of 4 patients who died of aspergillus infection had an absolute neutrophil count less than 1,300 cells/µL at time of operation. The mean absolute neutrophil count of the patients who cleared the aspergillus infection was 5,538 cells/µL. The mean survival of allogenic bone marrow transplant recipients was 5.2 months, and for recipients of autografts was 51.4 months.
Conclusions. In this series, surgical resection of IPA cleared the aspergillus infection in 69% of the patients. Neutropenia, extrapulmonic extension of IPA, and allogenic bone marrow transplantation may predict a worse prognosis. Surgical resection of IPA in immunocompromised patients is an effective form of therapy in a properly selected patient population.
This article has been cited by other articles:
|
|
 |
|
  S. Theodore, M. Liava'a, P. Antippa, R. Wynne, A. Grigg, M. Slavin, and J. Tatoulis Surgical management of invasive pulmonary fungal infection in hematology patients. Ann. Thorac. Surg., May 1, 2009; 87(5): 1532 - 1538. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. C. Danner, V. Didilis, H. Dorge, D. Mikroulis, G. Bougioukas, and F. A. Schondube Surgical treatment of pulmonary aspergillosis/mycosis in immunocompromised patients Interactive CardioVascular and Thoracic Surgery, October 1, 2008; 7(5): 771 - 776. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Bulpa, A. Dive, and Y. Sibille Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease Eur. Respir. J., October 1, 2007; 30(4): 782 - 800. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. G. Akbari, P. K. Varma, P. K. Neema, M. U. Menon, and K. S. Neelakandhan Clinical Profile and Surgical Outcome for Pulmonary Aspergilloma: A Single Center Experience Ann. Thorac. Surg., September 1, 2005; 80(3): 1067 - 1072. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Singh and D. L. Paterson Aspergillus Infections in Transplant Recipients Clin. Microbiol. Rev., January 1, 2005; 18(1): 44 - 69. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Matt, F. Bernet, J. Habicht, F. Gambazzi, A. Gratwohl, H.-R. Zerkowski, and M. Tamm Predicting Outcome After Lung Resection for Invasive Pulmonary Aspergillosis in Patients With Neutropenia Chest, December 1, 2004; 126(6): 1783 - 1788. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.M. Habicht, M. Preiss, J. Passweg, P. Dalquen, P. Matt, H. Adler, R. Frei, and H.-R. Zerkowski Invasive pulmonary aspergillosis: effects of early resection in a neutropenic rat model Eur. J. Cardiothorac. Surg., November 1, 2002; 22(5): 728 - 732. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. K. Park and S. Jheon Results of surgical treatment for pulmonary aspergilloma Eur. J. Cardiothorac. Surg., May 1, 2002; 21(5): 918 - 923. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Gossot, P. Validire, R. Vaillancourt, G. Socie, H. Esperou, A. Devergie, P. Guardiola, D. Grunenwald, E. Gluckman, and P. Ribaud Full thoracoscopic approach for surgical management of invasive pulmonary aspergillosis Ann. Thorac. Surg., January 1, 2002; 73(1): 240 - 244. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Al-Kattan, M. Ashour, W. Hajjar, M. Salah El Din, M. Fouda, and A. Al Bakry Surgery for pulmonary aspergilloma in post-tuberculous vs. immuno-compromised patients Eur. J. Cardiothorac. Surg., October 1, 2001; 20(4): 728 - 733. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Kudoh, N. Suzuki, N. Hatakeyama, N. Mizue, T. Hori, T. Oda, J. Watanabe, M. Imamura, and S. Chiba Successful Unrelated Cord Blood Transplantation in Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia During Pulmonary Aspergillosis Treated by Anti-fungal Therapy, Granulocyte Colony-stimulating Factor-mobilized Granulocytes and Surgical Resection: Case Report Jpn. J. Clin. Oncol., June 1, 2001; 31(6): 290 - 293. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Reichenberger, J.M. Habicht, A. Gratwohl, and M. Tamm Diagnosis and treatment of invasive pulmonary aspergillosis in neutropenic patients Eur. Respir. J., January 1, 2001; 19(4): 743 - 755. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Habicht, J. Passweg, T. Kuhne, K. Leibundgut, and H.-R. Zerkowski SUCCESSFUL LOCAL EXCISION AND LONG-TERM SURVIVAL FOR INVASIVE PULMONARY ASPERGILLOSIS DURING NEUTROPENIA AFTER BONE MARROW TRANSPLANTATION J. Thorac. Cardiovasc. Surg., June 1, 2000; 119(6): 1286 - 1287. [Full Text] [PDF]
|
|
|
|
|
|
G. Babatasi, M. Massetti, A. Chapelier, E. Fadel, P. Macchiarini, A. Khayat, and P. Dartevelle Surgical treatment of pulmonary aspergilloma: Current outcome J. Thorac. Cardiovasc. Surg., May 1, 2000; 119(5): 906 - 912. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-F. Regnard, P. Icard, M. Nicolosi, L. Spagiarri, P. Magdeleinat, B. Jauffret, and P. Levasseur Aspergilloma: a series of 89 surgical cases Ann. Thorac. Surg., March 1, 2000; 69(3): 898 - 903. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. C. Iwen, L. Sigler, S. Tarantolo, D. A. Sutton, M. G. Rinaldi, R. P. Lackner, D. I. McCarthy, and S. H. Hinrichs Pulmonary Infection Caused by Gymnascella hyalinospora in a Patient with Acute Myelogenous Leukemia J. Clin. Microbiol., January 1, 2000; 38(1): 375 - 381. [Abstract] [Full Text]
|
|
|
|
|
|
J. M. Habicht, F. Reichenberger, A. Gratwohl, H.-R. Zerkowski, and M. Tamm Surgical aspects of resection for suspected invasive pulmonary fungal infection in neutropenic patients Ann. Thorac. Surg., August 1, 1999; 68(2): 321 - 325. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-P. Latge Aspergillus fumigatus and Aspergillosis Clin. Microbiol. Rev., April 1, 1999; 12(2): 310 - 350. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
